Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Shandong Lukang Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Revenue

¥5.7 B

FY, 2025

CreditSafe Score

?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

CNYFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue3.2B3.7B4.1B4.8B5.5B6.0B6.1B5.7B
Cost of goods sold2.3B2.7B3.2B3.7B4.4B4.6B4.7B4.5B
Gross profit994.5M1.0B942.5M1.1B1.2B1.5B1.4B1.2B
Gross profit margin, %28.1%23.0%23.6%21.8%24.3%23.6%21.5%
Operating expense total528.7M614.2M568.9M630.3M598.5M765.3M692.1M558.3M
Depreciation and amortization228.3M217.7M245.7M307.6M347.0M383.5M419.7M446.4M
EBITDA469.0M415.2M376.1M506.0M591.2M689.2M739.3M651.5M
EBITDA margin, %11.4%9.2%10.5%10.8%11.5%12.1%11.5%
EBIT213.5M185.6M327.3M185.0M234.9M346.7M495.1M223.5M
EBIT margin, %5.1%8.0%3.8%4.3%5.8%8.1%4.0%
Interest income9.9M12.0M9.0M6.9M7.2M8.9M12.5M10.5M
Interest expense43.7M56.8M63.3M65.1M98.0M79.2M75.4M65.8M
Pre tax profit192.3M148.8M262.2M113.6M150.1M273.0M433.9M161.2M
Income tax expense18.9M20.0M28.7M23.7M7.0M16.2M25.6M49.3M
Net Income173.4M128.8M233.5M89.9M143.1M256.8M408.3M111.9M

Footer menu